https://www.selleckchem.com/EGFR(HER).html
Here, we review the biology, methodology, approaches, and clinical applications of biomarkers used to assess liquid biopsies. The current review addresses recent technological advances and different forms of liquid biopsy along with upcoming challenges and how they can be integrated to get the best possible tumor-derived genetic information that can be leveraged to more precise therapies for patient as liquid biopsies become increasingly routine in clinical practice. The treatment of acute pulmonary embolism (PE) with an intermediate-high risk
Like
Comment
Share
